Literature DB >> 15543205

Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis.

Isabel Devesa1, Maria Luisa Ferrándiz, Isabel Guillén, José Miguel Cerdá, Maria José Alcaraz.   

Abstract

Rat adjuvant arthritis is an experimental model widely used to evaluate etiopathogenetic mechanisms in chronic inflammation. We have examined the participation of heme oxygenase-1 (HO-1) in this experimental arthritis. In this study, an increased nitric oxide (NO) production in the paw preceded the upregulation of HO-1, whereas selective inhibition of inducible NO synthase (iNOS) after the onset of arthritis decreased HO-1 expression, suggesting that the induction of this enzyme may depend on NO produced by iNOS. Therapeutic administration of the HO-1 inhibitor tin protoporphyrin IX was able to control the symptoms of arthritis. This agent significantly decreased leukocyte infiltration, hyperplastic synovitis, erosion of articular cartilage and osteolysis, as well as the production of inflammatory mediators. In this experimental model, HO-1 can be involved in vascular endothelial growth factor production and angiogenesis. These results support a role for HO-1 in mediating the progression of the disease in this model of chronic arthritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15543205     DOI: 10.1038/labinvest.3700205

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Selective expansion of CD16highCCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase (HO)-1 in response to acute inflammation.

Authors:  K Mizuno; T Toma; H Tsukiji; H Okamoto; H Yamazaki; K Ohta; K Ohta; Y Kasahara; S Koizumi; A Yachie
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Heme oxygenase-1/biliverdin/carbon monoxide pathway downregulates hypernociception in rats by a mechanism dependent on cGMP/ATP-sensitive K+ channels.

Authors:  Hellíada Vasconcelos Chaves; Danielle Rocha do Val; Kátia Alves Ribeiro; Jonas Cavalcante Lemos; Ricardo Basto Souza; Francisco Isaac Fernandes Gomes; Rodrigo Maranguape Silva da Cunha; Vicente de Paulo Teixeira Pinto; Gerardo Cristino Filho; Marcellus Henrique Loiola Ponte de Souza; Mirna Marques Bezerra; Gerly Anne de Castro Brito
Journal:  Inflamm Res       Date:  2018-01-23       Impact factor: 4.575

3.  Anti-inflammatory and antihyperalgesic effects of the combination of ibuprofen and hemin in adjuvant-induced arthritis in the Wistar rat.

Authors:  Shamsherjit Kaur; Krishna Reddy V Bijjem; Pyare Lal Sharma
Journal:  Inflammopharmacology       Date:  2011-08-21       Impact factor: 4.473

Review 4.  Therapeutic potential of HO-1 in autoimmune diseases.

Authors:  Bao-Zhu Li; Biao Guo; Hai-Yan Zhang; Juan Liu; Sha-Sha Tao; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 5.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.

Authors:  Jozef Dulak; Jessy Deshane; Alicja Jozkowicz; Anupam Agarwal
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

Review 6.  Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy.

Authors:  Józef Dulak; Alicja Józkowicz
Journal:  Curr Cancer Drug Targets       Date:  2005-12       Impact factor: 3.428

Review 7.  Heme Catabolic Pathway in Inflammation and Immune Disorders.

Authors:  Bing Wu; Yanwei Wu; Wei Tang
Journal:  Front Pharmacol       Date:  2019-07-24       Impact factor: 5.810

Review 8.  Naturally Derived Heme-Oxygenase 1 Inducers and Their Therapeutic Application to Immune-Mediated Diseases.

Authors:  Samanta C Funes; Mariana Rios; Ayleen Fernández-Fierro; Camila Covián; Susan M Bueno; Claudia A Riedel; Juan Pablo Mackern-Oberti; Alexis M Kalergis
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.